Srs Capital Advisors, Inc. Pulse Biosciences, Inc. Transaction History
Srs Capital Advisors, Inc.
- $977 Million
- Q2 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 244 shares of PLSE stock, worth $4,026. This represents 0.0% of its overall portfolio holdings.
Number of Shares
244Holding current value
$4,026% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PLSE
# of Institutions
60Shares Held
4.78MCall Options Held
138KPut Options Held
96.2K-
Black Rock Inc. New York, NY1.15MShares$18.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA905KShares$14.9 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC783KShares$12.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA424KShares$7 Million0.0% of portfolio
-
State Street Corp Boston, MA392KShares$6.46 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $613M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...